Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 14 Tumor-Agnostic 9 Head & Neck 9 Gynecologic 7 Gastrointestinal 5 Breast 3 Sarcoma 1 Other hematologic neoplasm 1 Genitourinary 1 Dermatologic 1

Conditions

Sarcoma 16 Ovarian Neoplasms 8 Hemangiosarcoma 7 Endometrial Neoplasms 7 Carcinosarcoma 7 Breast Neoplasms 6 Sarcoma, Kaposi 4 Neoplasms 4 Melanoma 4 Lymphoma, Non-Hodgkin 4 Central Nervous System Neoplasms 4 Brain Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Medulloblastoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Gliosarcoma 3 Glioma 3 Glioblastoma 3 Gastrointestinal Stromal Tumors 3 Fallopian Tube Neoplasms 3 Carcinoma, Renal Cell 3

Interventions

pembrolizumab 3 Oncolytic Virotherapy 2 Fluorouracil 2 Cyclophosphamide 2 Cetuximab 2 trebananib 1 spartalizumab 1 repotrectinib 1 pemigatinib 1 patritumab 1 fludarabine phosphate 1 fludarabine 1 etoposide phosphate 1 darinaparsin 1 apatinib 1 Tetanus Toxoid 1 Sirolimus 1 Paclitaxel 1 Mesna 1 Ipilimumab 1 Injections 1 Etoposide 1 Cisplatin 1 Celecoxib 1 Carboplatin 1 Blood Specimen Collection 1 Ascorbic Acid 1 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × Paclitaxel × Sarcoma × Clear all

NCT01992341 2014-09-23

AMG 386 Drug-Drug Interaction Study With Paclitaxel

Amgen

Phase 1 Completed

Carcinoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡